Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12030)
All Articles published online
|
Publishing Process of This Article
|
Mar 7, 2014 (publication date) through Jun 17, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rucki AA, Zheng L. Pancreatic cancer stroma: Understanding biology leads to new therapeutic strategies. World J Gastroenterol 2014; 20(9): 2237-2246 [PMID: 24605023 DOI: 10.3748/wjg.v20.i9.2237] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i9/2237.htm |
| Number | Citing Articles |
| 1 |
Ruoxiang Wang, Gina Chia-Yi Chu, Haiyen E. Zhau, Leland W. K. Chung. Effect of Spaceflight and Spaceflight Analogue Culture on Human and Microbial Cells. 2016; : 131 doi: 10.1007/978-1-4939-3277-1_7
|
| 2 |
Jennifer L. Pretz, Michael A. Blake, Joseph H. Killoran, Harvey J. Mamon, Jennifer Y. Wo, Andrew X. Zhu, Theodore S. Hong. Pilot study on the impact of F18-labeled thymidine PET/CT on gross tumor volume identification and definition for pancreatic cancer. Practical Radiation Oncology 2018; 8(3): 179 doi: 10.1016/j.prro.2017.09.008
|
| 3 |
Bolun Jiang, Li Zhou, Jun Lu, Yizhi Wang, Chengxi Liu, Lei You, Junchao Guo. Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides?. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.576399
|
| 4 |
Jun Zhao, Huamin Wang, Cheng-Hui Hsiao, Diana S.-L. Chow, Eugene J. Koay, Yaan Kang, Xiaoxia Wen, Qian Huang, Ying Ma, James A. Bankson, Stephen E. Ullrich, Willem Overwijk, Anirban Maitra, David Piwnica-Worms, Jason B. Fleming, Chun Li. Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapy. Biomaterials 2018; 159: 215 doi: 10.1016/j.biomaterials.2018.01.014
|
| 5 |
David Vetvicka, Ladislav Sivak, Chinmay M. Jogdeo, Raj Kumar, Rubayat Khan, Yu Hang, David Oupický. Gene silencing delivery systems for the treatment of pancreatic cancer: Where and what to target next?. Journal of Controlled Release 2021; 331: 246 doi: 10.1016/j.jconrel.2021.01.020
|
| 6 |
Wenxi Zhou, Xinli Chen, Yu Zhou, Si Shi, Chen Liang, Xianjun Yu, Hongyi Chen, Qin Guo, Yiwen Zhang, Peixin Liu, Chao Li, Yongchao Chu, Yifan Luo, Yu Wang, Zheng Zhou, Zhenhao Zhao, Qinjun Chen, Tao Sun, Chen Jiang. Exosomes derived from immunogenically dying tumor cells as a versatile tool for vaccination against pancreatic cancer. Biomaterials 2022; 280: 121306 doi: 10.1016/j.biomaterials.2021.121306
|
| 7 |
Tasuku Matsuoka, Masakazu Yashiro. Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies. World Journal of Gastroenterology 2016; 22(2): 776-789 doi: 10.3748/wjg.v22.i2.776
|
| 8 |
Shrey Modi, Bhuwan Giri, Vineet K. Gupta, Shweta Lavania, Vrishketan Sethi, Nikita S. Sharma, Somnath Pandey, Selwyn Vickers, Vikas Dudeja, Ashok K. Saluja. Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancreatic cancer. Cancer Letters 2022; 537: 215591 doi: 10.1016/j.canlet.2022.215591
|
| 9 |
Emma Eriksson, Ioanna Milenova, Jessica Wenthe, Rafael Moreno, Ramon Alemany, Angelica Loskog. IL-6 Signaling Blockade during CD40-Mediated Immune Activation Favors Antitumor Factors by Reducing TGF-β, Collagen Type I, and PD-L1/PD-1. The Journal of Immunology 2019; 202(3): 787 doi: 10.4049/jimmunol.1800717
|
| 10 |
Richard A. Skelton, Ammar Javed, Lei Zheng, Jin He. Overcoming the resistance of pancreatic cancer to immune checkpoint inhibitors. Journal of Surgical Oncology 2017; 116(1): 55 doi: 10.1002/jso.24642
|
| 11 |
Beisong Xu. Report on History of FDA and NMPA and Traditional and Future Methods of Treating Cancer. Proceedings of the 2021 International Conference on Intelligent Medicine and Health 2021; : 109 doi: 10.1145/3484377.3484396
|
| 12 |
Charles Pottier, Alodie Wheatherspoon, Patrick Roncarati, Rémi Longuespée, Michael Herfs, Anaelle Duray, Philippe Delvenne, Pascale Quatresooz. The importance of the tumor microenvironment in the therapeutic management of cancer. Expert Review of Anticancer Therapy 2015; 15(8): 943 doi: 10.1586/14737140.2015.1059279
|
| 13 |
Zhengsheng Liu, Ling Zhang, Zhou Tian, Chao Kong, Chun Liu, Huiqin Liu, Fang Yuan, Weijian Kong, Feng Qian. Paclitaxel and Itraconazole Co‐Encapsulated Micelle Prolongs the Survival of Spontaneous LSL‐KrasG12D/+, LSL‐Trp53R172H/+, Pdx‐1‐Cre Genetically Engineered Mouse Model of Pancreatic Cancer. Advanced Therapeutics 2019; 2(9) doi: 10.1002/adtp.201900032
|
| 14 |
Yu Liu, Wei Wu, Yiyao Wang, Shisong Han, Yuanyuan Yuan, Jinsheng Huang, Xintao Shuai, Zhao Peng. Recent development of gene therapy for pancreatic cancer using non-viral nanovectors. Biomaterials Science 2021; 9(20): 6673 doi: 10.1039/D1BM00748C
|
| 15 |
Solange Moll, Matthias Meier, Ivan Formentini, Silvia Pomposiello, Marco Prunotto. New renal drug development to face chronic renal disease. Expert Opinion on Drug Discovery 2014; 9(12): 1471 doi: 10.1517/17460441.2014.956075
|
| 16 |
Haimin Feng, Taiki Moriyama, Kenoki Ohuchida, Nan Sheng, Chika Iwamoto, Koji Shindo, Kengo Shirahane, Naoki Ikenaga, Shuntaro Nagai, Kohei Nakata, Kazuhiro Mizumoto, Masafumi Nakamura. N-acetyl cysteine induces quiescent-like pancreatic stellate cells from an active state and attenuates cancer-stroma interactions. Journal of Experimental & Clinical Cancer Research 2021; 40(1) doi: 10.1186/s13046-021-01939-1
|
| 17 |
Wenxi Zhou, Yu Zhou, Xinli Chen, Tingting Ning, Hongyi Chen, Qin Guo, Yiwen Zhang, Peixin Liu, Yujie Zhang, Chao Li, Yongchao Chu, Tao Sun, Chen Jiang. Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment. Biomaterials 2021; 268: 120546 doi: 10.1016/j.biomaterials.2020.120546
|
| 18 |
Isabel Mejia, Sandhya Bodapati, Kathryn T. Chen, Begoña Díaz. Pancreatic Adenocarcinoma Invasiveness and the Tumor Microenvironment: From Biology to Clinical Trials. Biomedicines 2020; 8(10): 401 doi: 10.3390/biomedicines8100401
|
| 19 |
Tarak Chouari, Francesca Soraya La Costa, Nabeel Merali, Maria-Danae Jessel, Shivan Sivakumar, Nicola Annels, Adam E. Frampton. Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma. Cancers 2023; 15(17): 4265 doi: 10.3390/cancers15174265
|
| 20 |
Reinhild Holmer, Freya A Goumas, Georg H Waetzig, Stefan Rose-John, Holger Kalthoff. Interleukin-6: a villain in the drama of pancreatic cancer development and progression. Hepatobiliary & Pancreatic Diseases International 2014; 13(4): 371 doi: 10.1016/S1499-3872(14)60259-9
|
| 21 |
Sandeep Kumar, Sunil Kumar Singh, Piush Srivastava, Swathi Suresh, Basabi Rana, Ajay Rana. Pancreatic Cancer: Basic Mechanisms and Therapies. Advances in Cancer Research 2023; 159: 113 doi: 10.1016/bs.acr.2023.02.003
|
| 22 |
Masanori Tsujie, Soichi Fumita, Tomoko Wakasa, Shigeto Mizuno, Hajime Ishikawa, Kotaro Kitani, Shumpei Satoi, Kaoru Okada, Keisuke Inoue, Shuichi Fukuda, Hironobu Manabe, Noriko Ichimura, Shinya Ueda, Takao Tamura, Toshihiko Kawasaki, Masao Yukawa, Yoshio Ohta, Masatoshi Inoue. A Case of Pathological Complete Response Following FOLFIRINOX Therapy for Pancreatic Adenocarcinoma with Synchronous Distant Lymph Node Metastases. International Journal of Surgery Case Reports 2020; 72: 471 doi: 10.1016/j.ijscr.2020.06.044
|
| 23 |
Xuan Zhang, Zhiming Zeng, Huiyi Liu, Li Xu, Xin Sun, Jing Xu, Guosheng Song. Recent development of a magneto-optical nanoplatform for multimodality imaging of pancreatic ductal adenocarcinoma. Nanoscale 2022; 14(9): 3306 doi: 10.1039/D1NR08394E
|
| 24 |
Sreenivasa Chandana, Hani M. Babiker, Daruka Mahadevan. Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC). Expert Opinion on Investigational Drugs 2019; 28(2): 161 doi: 10.1080/13543784.2019.1557145
|
| 25 |
Pavan P. Adiseshaiah, Rachael M. Crist, Sara S. Hook, Scott E. McNeil. Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer. Nature Reviews Clinical Oncology 2016; 13(12): 750 doi: 10.1038/nrclinonc.2016.119
|
| 26 |
Yu Yu, Jiuwei Cui. Present and future of cancer immunotherapy: A tumor microenvironmental perspective (Review). Oncology Letters 2018; doi: 10.3892/ol.2018.9219
|
| 27 |
Manoj K. Bhasin, Kenneth Ndebele, Octavian Bucur, Eric U. Yee, Hasan H. Otu, Jessica Plati, Andrea Bullock, Xuesong Gu, Eduardo Castan, Peng Zhang, Robert Najarian, Maria S. Muraru, Rebecca Miksad, Roya Khosravi-Far, Towia A. Libermann. Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier. Oncotarget 2016; 7(17): 23263 doi: 10.18632/oncotarget.8139
|
| 28 |
Vincenzo Ricci, Teresa Fabozzi, Maria Anna Bareschino, Emiddio Barletta, Domenico Germano, Immacolata Paciolla, Vincenza Tinessa, Antonio Maria Grimaldi. Pancreatic Cancer: Beyond Brca Mutations. Journal of Personalized Medicine 2022; 12(12): 2076 doi: 10.3390/jpm12122076
|
| 29 |
Maria Miquel, Shuman Zhang, Christian Pilarsky. Pre-clinical Models of Metastasis in Pancreatic Cancer. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.748631
|
| 30 |
Ankit Sahoo, Kainat Alam, Shipra Daniel, Sarwar Beg, Vikas Kumar, Abdul Hafeez, Mahfoozur Rahman, Waleed H. Almalki. Hormone Related Cancer Mechanistic and Nanomedicines. 2022; : 129 doi: 10.1007/978-981-19-5558-7_7
|
| 31 |
Anteneh A. Tesfaye, Mandana Kamgar, Asfar Azmi, Philip A. Philip. The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities. Expert Review of Anticancer Therapy 2018; 18(2): 131 doi: 10.1080/14737140.2018.1417844
|
| 32 |
Laura Witteck, Robert Jaster. Trametinib and dactolisib but not regorafenib exert antiproliferative effects on rat pancreatic stellate cells. Hepatobiliary & Pancreatic Diseases International 2015; 14(6): 642 doi: 10.1016/S1499-3872(15)60032-7
|
| 33 |
Carina Strell, Karin Jessica Norberg, Artur Mezheyeuski, Jonas Schnittert, Praneeth R Kuninty, Carlos Fernández Moro, Janna Paulsson, Nicolai Aagaard Schultz, Dan Calatayud, Johannes Matthias Löhr, Oliver Frings, Caroline Sophie Verbeke, Rainer Lothar Heuchel, Jai Prakash, Julia Sidenius Johansen, Arne Östman. Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC. British Journal of Cancer 2017; 117(1): 65 doi: 10.1038/bjc.2017.140
|
| 34 |
Lenka N.C. Boyd, Katarina D. Andini, Godefridus J. Peters, Geert Kazemier, Elisa Giovannetti. Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment. Seminars in Cancer Biology 2022; 82: 184 doi: 10.1016/j.semcancer.2021.03.006
|
| 35 |
Ahmad R. Cheema, Eileen M. O’Reilly. Management of Metastatic Pancreatic Adenocarcinoma. Surgical Clinics of North America 2016; 96(6): 1391 doi: 10.1016/j.suc.2016.07.011
|
| 36 |
Sarah Mansouri, Lauren Daniel, Nawal Amhis, Maxime Leveille, Jeanette E. Boudreau, Almohanad A. Alkayyal, Yves Collin, Lee-Hwa Tai. Perioperative oncolytic virotherapy to counteract surgery-induced immunosuppression and improve outcomes in pancreatic ductal adenocarcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1071751
|
| 37 |
Hiroyoshi Y. Tanaka, Kentaro Kitahara, Naoki Sasaki, Natsumi Nakao, Kae Sato, Hirokazu Narita, Hiroshi Shimoda, Michiya Matsusaki, Hiroshi Nishihara, Atsushi Masamune, Mitsunobu R. Kano. Pancreatic stellate cells derived from human pancreatic cancer demonstrate aberrant SPARC-dependent ECM remodeling in 3D engineered fibrotic tissue of clinically relevant thickness. Biomaterials 2019; 192: 355 doi: 10.1016/j.biomaterials.2018.11.023
|
| 38 |
Stephen T. Muth, May Tun Saung, Alex B. Blair, MacKenzie G. Henderson, Dwayne L. Thomas, Lei Zheng. CD137 agonist-based combination immunotherapy enhances activated, effector memory T cells and prolongs survival in pancreatic adenocarcinoma. Cancer Letters 2021; 499: 99 doi: 10.1016/j.canlet.2020.11.041
|
| 39 |
Betty Laverdet, Dorothée Girard, Alexis Desmoulière. Physiologie de la peau, réparation cutanée et réaction stromale. Actualités Pharmaceutiques 2018; 57(581): 20 doi: 10.1016/j.actpha.2018.10.004
|
| 40 |
Chunping Liu, Dongyue He, Longmei Li, Shihui Zhang, Lei Wang, Zhijin Fan, Yichao Wang. Extracellular vesicles in pancreatic cancer immune escape: Emerging roles and mechanisms. Pharmacological Research 2022; 183: 106364 doi: 10.1016/j.phrs.2022.106364
|
| 41 |
Ningwei Wang, Xu Yan, Chaofei Ji, Jinlong Hu, Xiangshun Chen, Cong Zhang, Yuzhu Quan, Tao He, Tianci Sun, Yue Yu.
In situ thermal-responsive hydrogels for combined photothermal therapy and chemotherapy of pancreatic cancer . RSC Advances 2025; 15(17): 13119 doi: 10.1039/D5RA00371G
|
| 42 |
Christos Svoronos, Georgios Tsoulfas, Maria Souvatzi, Efthimios Chatzitheoklitos. Prognostic value of COL6A3 in pancreatic adenocarcinoma. Annals of Hepato-Biliary-Pancreatic Surgery 2020; 24(1): 52 doi: 10.14701/ahbps.2020.24.1.52
|
| 43 |
Tomas Koltai, Stephan Joel Reshkin, Tiago M. A. Carvalho, Rosa A. Cardone. Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer. International Journal of Molecular Sciences 2021; 22(8): 3953 doi: 10.3390/ijms22083953
|
| 44 |
Neus Martínez-Bosch, Pedro Enrique Guerrero, Mireia Moreno, Anabel José, Mar Iglesias, Jessica Munné-Collado, Héctor Anta, Joan Gibert, Carlos Alberto Orozco, Judith Vinaixa, Cristina Fillat, Francesc Viñals, Pilar Navarro. The pancreatic niche inhibits the effectiveness of sunitinib treatment of pancreatic cancer. Oncotarget 2016; 7(30): 48265 doi: 10.18632/oncotarget.10199
|
| 45 |
Tian-Jiao Li, Wen-Quan Wang, Xian-Jun Yu, Liang Liu. Killing the “BAD”: Challenges for immunotherapy in pancreatic cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(1): 188384 doi: 10.1016/j.bbcan.2020.188384
|
| 46 |
David J. Birnbaum, François Bertucci, Pascal Finetti, Daniel Birnbaum, Emilie Mamessier. Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2018; 1869(2): 248 doi: 10.1016/j.bbcan.2018.02.001
|
| 47 |
Aya Sugyo, Atsushi B. Tsuji, Hitomi Sudo, Maki Okada, Mitsuru Koizumi, Hirokazu Satoh, Gene Kurosawa, Yoshikazu Kurosawa, Tsuneo Saga, C Andrew Boswell. Evaluation of Efficacy of Radioimmunotherapy with 90Y-Labeled Fully Human Anti-Transferrin Receptor Monoclonal Antibody in Pancreatic Cancer Mouse Models. PLOS ONE 2015; 10(4): e0123761 doi: 10.1371/journal.pone.0123761
|
| 48 |
David J. Birnbaum, Sebastian K.S. Begg, Pascal Finetti, Charles Vanderburg, Anupriya S. Kulkarni, Azfar Neyaz, Thomas Hank, Eric Tai, Vikram Deshpande, François Bertucci, Daniel Birnbaum, Keith D. Lillemoe, Andrew L. Warshaw, Mari Mino-Kenudson, Carlos Fernandez-Del Castillo, David T. Ting, Andrew S. Liss. Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research 2021; 27(8): 2314 doi: 10.1158/1078-0432.CCR-20-1039
|
| 49 |
Yuanke Li, Zhen Zhao, Hao Liu, John Peter Fetse, Akshay Jain, Chien-Yu Lin, Kun Cheng. Development of a Tumor-Responsive Nanopolyplex Targeting Pancreatic Cancer Cells and Stroma. ACS Applied Materials & Interfaces 2019; 11(49): 45390 doi: 10.1021/acsami.9b15116
|
| 50 |
Koelina Ganguly, Jesse L. Cox, Dario Ghersi, Paul M. Grandgenett, Michael A. Hollingsworth, Maneesh Jain, Sushil Kumar, Surinder K. Batra. Mucin 5AC–Mediated CD44/ITGB1 Clustering Mobilizes Adipose-Derived Mesenchymal Stem Cells to Modulate Pancreatic Cancer Stromal Heterogeneity. Gastroenterology 2022; 162(7): 2032 doi: 10.1053/j.gastro.2022.02.032
|
| 51 |
Mohana Chakkera, Jeremy B. Foote, Batoul Farran, Ganji Purnachandra Nagaraju. Breaking the stromal barrier in pancreatic cancer: Advances and challenges. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024; 1879(1): 189065 doi: 10.1016/j.bbcan.2023.189065
|
| 52 |
Saira Rafaqat, Huma Khurshid, Ramsha Hafeez, Mehnaz Arif, Ayesha Zafar, Mahrukh Gilani, Habiba Ashraf, Sana Rafaqat. Role of Interleukins in Pancreatic Cancer: A Literature Review. Journal of Gastrointestinal Cancer 2024; 55(4): 1498 doi: 10.1007/s12029-024-01111-w
|
| 53 |
Jian Xu, Youting Chen, Hong Chen, Zhipeng Hong, Zheng Shi, Shuangmu Zhuo, Xiaoqin Zhu, Jianxin Chen. Identifying the neck margin status of ductal adenocarcinoma in the pancreatic head by multiphoton microscopy. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-04771-w
|
| 54 |
Alex B. Blair, Victoria M. Kim, Stephen T. Muth, May Tun Saung, Nathalie Lokker, Barbara Blouw, Todd D. Armstrong, Elizabeth M. Jaffee, Takahiro Tsujikawa, Lisa M. Coussens, Jin He, Richard A. Burkhart, Christopher L. Wolfgang, Lei Zheng. Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic Cancer. Clinical Cancer Research 2019; 25(17): 5351 doi: 10.1158/1078-0432.CCR-18-4192
|
| 55 |
Liang Liu, Xinyu Xiao, Jiao Guo, Jianwei Wang, Shanshan Liu, Meijiao Wang, Qiling Peng, Ning Jiang. Aptamer and Peptide-Engineered Polydopamine Nanospheres for Target Delivery and Tumor Perfusion in Synergistic Chemo-Phototherapy of Pancreatic Cancer. ACS Applied Materials & Interfaces 2023; 15(13): 16539 doi: 10.1021/acsami.3c01967
|
| 56 |
Agnieszka A. Rucki, Qian Xiao, Stephen Muth, Jianlin Chen, Xu Che, Jennifer Kleponis, Rajni Sharma, Robert A. Anders, Elizabeth M. Jaffee, Lei Zheng. Dual Inhibition of Hedgehog and c-Met Pathways for Pancreatic Cancer Treatment. Molecular Cancer Therapeutics 2017; 16(11): 2399 doi: 10.1158/1535-7163.MCT-16-0452
|
| 57 |
Xinxin Meng, Fengyun Ma, Dingli Yu. The diverse effects of cisplatin on tumor microenvironment: Insights and challenges for the delivery of cisplatin by nanoparticles. Environmental Research 2024; 240: 117362 doi: 10.1016/j.envres.2023.117362
|
| 58 |
Han-xiang Zhan, Bin Zhou, Yu-gang Cheng, Jian-wei Xu, Lei Wang, Guang-yong Zhang, San-yuan Hu. Crosstalk between stromal cells and cancer cells in pancreatic cancer: New insights into stromal biology. Cancer Letters 2017; 392: 83 doi: 10.1016/j.canlet.2017.01.041
|
| 59 |
Demi S. Houg, Maarten F. Bijlsma. The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma. Molecular Cancer 2018; 17(1) doi: 10.1186/s12943-018-0842-9
|
| 60 |
Agnieszka A. Rucki, Kelly Foley, Pingbo Zhang, Qian Xiao, Jennifer Kleponis, Annie A. Wu, Rajni Sharma, Guanglan Mo, Angen Liu, Jennifer Van Eyk, Elizabeth M. Jaffee, Lei Zheng. Heterogeneous Stromal Signaling within the Tumor Microenvironment Controls the Metastasis of Pancreatic Cancer. Cancer Research 2017; 77(1): 41 doi: 10.1158/0008-5472.CAN-16-1383
|
| 61 |
Rosella Spadi, Federica Brusa, Agostino Ponzetti, Isabella Chiappino, Nadia Birocco, Libero Ciuffreda, Maria Antonietta Satolli. Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians. World Journal of Clinical Oncology 2016; 7(1): 27-43 doi: 10.5306/wjco.v7.i1.27
|
| 62 |
Xu Liu, Yang Cheng, Yao Mu, Zhaohan Zhang, Dan Tian, Yunpeng Liu, Xuejun Hu, Ti Wen. Diverse drug delivery systems for the enhancement of cancer immunotherapy: an overview. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1328145
|
| 63 |
Ting Xue, Peijia Xu, Jonathan Padelford, Xingkui Xue, Alyssa Y. Wu, Yuancheng Li, Liya Wang. Actively targeted delivery of SN38 by ultrafine iron oxide nanoparticle for treating pancreatic cancer. Investigational New Drugs 2022; 40(3): 546 doi: 10.1007/s10637-022-01231-9
|
| 64 |
Bala Prabhakar Girish, Begum Dariya, Mastan Mannarapu, Ganji Purnachandra Nagaraju, Ganji Seeta Rama Raju. Targeting the tumor microenvironment of pancreatic ductal adenocarcinoma using nano-phytomedicines. Seminars in Cancer Biology 2022; 86: 1155 doi: 10.1016/j.semcancer.2021.06.014
|
| 65 |
Petr Busek, Zdislava Vanickova, Petr Hrabal, Marek Brabec, Premysl Fric, Miroslav Zavoral, Jan Skrha, Klara Kmochova, Martin Laclav, Bohus Bunganic, Koen Augustyns, Pieter Van Der Veken, Aleksi Sedo. Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinoma. Pancreatology 2016; 16(5): 829 doi: 10.1016/j.pan.2016.06.001
|
| 66 |
Annalisa Pappalardo, Emilio Francesco Giunta, Giuseppe Tirino, Luca Pompella, Piera Federico, Bruno Daniele, Ferdinando De Vita, Angelica Petrillo. Adjuvant Treatment in Pancreatic Cancer: Shaping the Future of the Curative Setting. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.695627
|
| 67 |
Afsane Bahrami, Majid Khazaei, Fariba Bagherieh, Majid Ghayour‐Mobarhan, Mina Maftouh, Seyed Mahdi Hassanian, Amir Avan. Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies. Journal of Cellular Physiology 2017; 232(11): 2931 doi: 10.1002/jcp.25798
|
| 68 |
Daniel R. Principe, Patrick W. Underwood, Murray Korc, Jose G. Trevino, Hidayatullah G. Munshi, Ajay Rana. The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.688377
|
| 69 |
Kelly Foley, Victoria Kim, Elizabeth Jaffee, Lei Zheng. Current progress in immunotherapy for pancreatic cancer. Cancer Letters 2016; 381(1): 244 doi: 10.1016/j.canlet.2015.12.020
|
| 70 |
Dingyuan Hu, Daniel Ansari, Krzysztof Pawłowski, Qimin Zhou, Agata Sasor, Charlotte Welinder, Theresa Kristl, Monika Bauden, Melinda Rezeli, Yi Jiang, György Marko-Varga, Roland Andersson. Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma. Oncotarget 2018; 9(11): 9789 doi: 10.18632/oncotarget.23929
|
| 71 |
Satoshi Sakai, Caname Iwata, Hiroyoshi Y. Tanaka, Horacio Cabral, Yasuyuki Morishita, Kohei Miyazono, Mitsunobu R. Kano. Increased fibrosis and impaired intratumoral accumulation of macromolecules in a murine model of pancreatic cancer co-administered with FGF-2. Journal of Controlled Release 2016; 230: 109 doi: 10.1016/j.jconrel.2016.04.007
|
| 72 |
Ann Mary Joseph, Ahmad Al Aiyan, Basel Al-Ramadi, Shiv K. Singh, Uday Kishore. Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1323198
|
| 73 |
Michael Friberg Bruun Nielsen, Michael Bau Mortensen, Sönke Detlefsen. Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells. World Journal of Gastroenterology 2016; 22(9): 2678-2700 doi: 10.3748/wjg.v22.i9.2678
|
| 74 |
Fabio Grizzi, Sirio Fiorino, Dorina Qehajaj, Adele Fornelli, Carlo Russo, Dario de Biase, Michele Masetti, Laura Mastrangelo, Matteo Zanello, Raffaele Lombardi, Andrea Domanico, Esterita Accogli, Andrea Tura, Leonardo Mirandola, Maurizio Chiriva-Internati, Robert S. Bresalier, Elio Jovine, Paolo Leandri, Luca Di Tommaso. Computer-aided assessment of the extra-cellular matrix during pancreatic carcinogenesis: a pilot study. Journal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-019-1817-3
|
| 75 |
Meng-wen Zhang, Kenji Fujiwara, Xu Che, Shu Zheng, Lei Zheng. DNA methylation in the tumor microenvironment. Journal of Zhejiang University-SCIENCE B 2017; 18(5): 365 doi: 10.1631/jzus.B1600579
|
| 76 |
Qian Xiao, Donger Zhou, Agnieszka A. Rucki, Jamila Williams, Jiaojiao Zhou, Guanglan Mo, Adrian Murphy, Kenji Fujiwara, Jennifer Kleponis, Bulent Salman, Christopher L. Wolfgang, Robert A. Anders, Shu Zheng, Elizabeth M. Jaffee, Lei Zheng. Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methylation. Cancer Research 2016; 76(18): 5395 doi: 10.1158/0008-5472.CAN-15-3264
|
| 77 |
Guojie Zhao, Changjing Wang, Jian Jiao, Wei Zhang, Hongwei Yang. The novel subclusters based on cancer-associated fibroblast for pancreatic adenocarcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1045477
|
| 78 |
Zachary Gao, Joseph Azar, Huili Zhu, Sophia Williams-Perez, Sung Wook Kang, Celia Marginean, Mark P. Rubinstein, Shalini Makawita, Hyun-Sung Lee, E. Ramsay Camp. Translational and oncologic significance of tertiary lymphoid structures in pancreatic adenocarcinoma. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1324093
|
| 79 |
Kedar Deodhar. PET/CT in Hepatobiliary and Pancreatic Malignancies. 2018; : 13 doi: 10.1007/978-3-319-60507-4_2
|
| 80 |
Krishan Kumar, Deepak Kanojia, David J. Bentrem, Rosa F. Hwang, Jonathan P. Butchar, Susheela Tridandapani, Hidayatullah G. Munshi. Targeting BET Proteins Decreases Hyaluronidase-1 in Pancreatic Cancer. Cells 2023; 12(11): 1490 doi: 10.3390/cells12111490
|
| 81 |
Andreia S. Fernandes, Catarina Oliveira, Rui L. Reis, Albino Martins, Tiago H. Silva. Marine-Inspired Drugs and Biomaterials in the Perspective of Pancreatic Cancer Therapies. Marine Drugs 2022; 20(11): 689 doi: 10.3390/md20110689
|
| 82 |
Giulia Brachi, Federico Bussolino, Gianluca Ciardelli, Clara Mattu. Nanomedicine for Imaging and Therapy of Pancreatic Adenocarcinoma. Frontiers in Bioengineering and Biotechnology 2019; 7 doi: 10.3389/fbioe.2019.00307
|
| 83 |
Shannon M. Gallagher‐Colombo, Jarod C. Finlay, Theresa M. Busch. Resistance to Photodynamic Therapy in Cancer. Resistance to Targeted Anti-Cancer Therapeutics 2015; 5: 65 doi: 10.1007/978-3-319-12730-9_3
|
| 84 |
Mohamed J. Saadh, Mohammed Ahmed Mustafa, H. Malathi, Gunveen Ahluwalia, Sumeet Kaur, Ahmed Naser Faisal, Mahmood Hasen Shuhata Alubiady, Salah Hassan Zain Al-Abdeen, Hussein Ghafel Shakier, Zainab H. Ali, Irfan Ahmad, Ahmed Hussein Zwamel. Nanoparticle-based targeting of pancreatic tumor stroma and extracellular matrix: A promising approach for improved treatment. Journal of Drug Delivery Science and Technology 2024; 99: 105938 doi: 10.1016/j.jddst.2024.105938
|
| 85 |
Noelle R. Jurcak, Agnieszka A. Rucki, Stephen Muth, Elizabeth Thompson, Rajni Sharma, Ding Ding, Qingfeng Zhu, James R. Eshleman, Robert A. Anders, Elizabeth M. Jaffee, Kenji Fujiwara, Lei Zheng. Axon Guidance Molecules Promote Perineural Invasion and Metastasis of Orthotopic Pancreatic Tumors in Mice. Gastroenterology 2019; 157(3): 838 doi: 10.1053/j.gastro.2019.05.065
|
| 86 |
Claudia Minici, Elena Rigamonti, Marco Lanzillotta, Antonella Monno, Lucrezia Rovati, Takashi Maehara, Naoki Kaneko, Vikram Deshpande, Maria Pia Protti, Lucia De Monte, Cristina Scielzo, Stefano Crippa, Paolo Giorgio Arcidiacono, Erica Dugnani, Lorenzo Piemonti, Massimo Falconi, Shiv Pillai, Angelo A. Manfredi, Emanuel Della-Torre. B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma. OncoImmunology 2020; 9(1) doi: 10.1080/2162402X.2020.1794359
|
| 87 |
Boju Pan, Quan Liao, Zheyu Niu, Li Zhou, Yupei Zhao. Cancer-Associated Fibroblasts in Pancreatic Adenocarcinoma. Future Oncology 2015; 11(18): 2603 doi: 10.2217/fon.15.176
|
| 88 |
Huiqin Liu, Yu Shi, Feng Qian. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts. Advanced Drug Delivery Reviews 2021; 172: 37 doi: 10.1016/j.addr.2021.02.012
|
| 89 |
Eric Struth, Maryam Labaf, Vida Karimnia, Yiran Liu, Gwendolyn Cramer, Joanna B. Dahl, Frank J. Slack, Kourosh Zarringhalam, Jonathan P. Celli. Drug resistant pancreatic cancer cells exhibit altered biophysical interactions with stromal fibroblasts in imaging studies of 3D co-culture models. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-71372-9
|
| 90 |
Maeve A. Lowery, Eileen M. O'Reilly. Novel Therapeutics for Pancreatic Adenocarcinoma. Hematology/Oncology Clinics of North America 2015; 29(4): 777 doi: 10.1016/j.hoc.2015.04.006
|
| 91 |
Emma Eriksson, Ioanna Milenova, Jessica Wenthe, Magnus Ståhle, Justyna Leja-Jarblad, Gustav Ullenhag, Anna Dimberg, Raphael Moreno, Ramon Alemany, Angelica Loskog. Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus. Clinical Cancer Research 2017; 23(19): 5846 doi: 10.1158/1078-0432.CCR-17-0285
|
| 92 |
Yaohui Fang, Chunlu Tan, Zhenjiang Zheng, Jianchen Yang, Jiali Tang, Ruizhe Guo, Epiphane K. Silli, Zhe Chen, Jia Chen, Ruyu Ge, Yuquan Liu, Xiuqi Wen, Jingdan Liang, Yunfei Zhu, Yutong Jin, Qian Li, Ying Wang. The function of microRNA related to cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Biochemical Pharmacology 2025; 236: 116849 doi: 10.1016/j.bcp.2025.116849
|
| 93 |
Awalpreet S. Chadha, Allison Khoo, Maureen L. Aliru, Harpreet K. Arora, Jillian R. Gunther, Sunil Krishnan. Recent Advances and Prospects for Multimodality Therapy in Pancreatic Cancer. Seminars in Radiation Oncology 2016; 26(4): 320 doi: 10.1016/j.semradonc.2016.05.002
|
| 94 |
Laleh G. Melstrom, Marcela D. Salazar, Don J. Diamond. The pancreatic cancer microenvironment: A true double agent. Journal of Surgical Oncology 2017; 116(1): 7 doi: 10.1002/jso.24643
|
| 95 |
Mariana Monteiro Val, Luís André Mendes, Ana Alarcão, Lina Carvalho, Isabel Carreira, Carlos Fernando D. Rodrigues, Maria Carmen Alpoim. Senescent bronchial fibroblasts induced to senescence by Cr(VI) promote epithelial–mesenchymal transition when co-cultured with bronchial epithelial cells in the presence of Cr(VI). Mutagenesis 2015; 30(2): 277 doi: 10.1093/mutage/geu070
|
| 96 |
Somala Mohammed, Sujita Sukumaran, Pradip Bajgain, Norihiro Watanabe, Helen E. Heslop, Cliona M. Rooney, Malcolm K. Brenner, William E. Fisher, Ann M. Leen, Juan F. Vera. Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer. Molecular Therapy 2017; 25(1): 249 doi: 10.1016/j.ymthe.2016.10.016
|
| 97 |
Janaiah Kota, Julie Hancock, Jason Kwon, Murray Korc. Pancreatic cancer: Stroma and its current and emerging targeted therapies. Cancer Letters 2017; 391: 38 doi: 10.1016/j.canlet.2016.12.035
|